Nat Rev Dis Prim 31(3):119
Amgen is exploring novel biologics and peptide-based therapies, including GLP-1 receptor agonists, aiming to expand treatment options for obesity and diabetes
Mice were randomized into seven groups: a saline control group (CON), a saline control treated with GHRP-6 (CON + GHRP-6), a doxorubicin-only group (DOX), a doxorubicin group treated with GHRP-6 (DOX + GHRP-6), a doxorubicin group treated with GHRP-6 and the GHSR antagonist YIL781 (DOX + GHRP-6 + YIL781), a doxorubicin group treated with GHRP-6 and the CCR5 antagonist TAK-779 (DOX + GHRP-6 + TAK-779), and finally a doxorubicin group treated with GHRP-6 alongside the CXCR4 antagonist AMD3100 (DOX + GHRP-6 + AMD3100)
Timing decision: Decide whether to keep morning levothyroxine dosing or switch to bedtime
The molecule comprises 31 amino acids , with a molecular mass of about 4113 Da
Great experience working with them